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Abstract
Most studies on dietary vegetable oil in rainbow trout (Oncorhynchus mykiss) have been conducted on a background of dietary EPA
(20 : 5n-3) and DHA (22 : 6n-3) contained in the ﬁshmeal used as a protein source in aquaculture feed. If dietary EPA and DHA repress their
endogenous synthesis from α-linolenic acid (ALA, 18 : 3n-3), then the potential of ALA-containing vegetable oils to maintain tissue EPA and
DHA has been underestimated. We examined the effect of individual dietary n-3 PUFA on the expression of the biosynthetic genes required
for metabolism of ALA to DHA in rainbow trout. A total of 720 juvenile rainbow trout were allocated to twenty-four experimental tanks and
assigned one of eight diets. The effect of dietary ALA, EPA or DHA, in isolation or in combination, on hepatic expression of fatty acyl
desaturase (FADS)2a(Δ6), FADS2b(Δ5), elongation of very long-chain fatty acid (ELOVL)5 and ELOVL2 was examined after 3 weeks of dietary
intervention. The effect of these diets on liver and muscle phospholipid PUFA composition was also examined. The expression levels of
FADS2a(Δ6), ELOVL5 and ELOVL2 were highest when diets were high in ALA, with no added EPA or DHA. Under these conditions ALA was
readily converted to tissue DHA. Dietary DHA had the largest and most consistent effect in down-regulating the gene expression of all four
genes. The ELOVL5 expression was the least responsive of the four genes to dietary n-3 PUFA changes. These ﬁndings should be considered
when optimising aquaculture feeds containing vegetable oils and/or ﬁsh oil or ﬁshmeal to achieve maximum DHA synthesis.
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The association of ﬁsh and ﬁsh oil with cardiac health is linked
closely to their contents of n-3 long-chain (LC) PUFA, especially
EPA (20 : 5n-3) and DHA (22 : 6n-3)(1). In wild ﬁsh, EPA and
DHA are obtained from the diet comprising of aquatic plants
and algae or other ﬁsh(2). In farmed ﬁsh, EPA and DHA have
been supplied by inclusion of ﬁshmeal and ﬁsh oil in feeds.
Because of the ﬁnite supply of ﬁsh oil that limits availability and
drives up the price, vegetable oils containing n-3 PUFA have
been used increasingly to replace ﬁsh oil in aquaculture feeds.
However, the n-3 PUFA content of vegetable oils is due to the
shorter-chain α-linolenic acid (ALA, 18 : 3n-3), and therefore an
important commercial issue is the ability of aquaculture species
to metabolise ALA to EPA and, in particular, to DHA.
In vertebrates the metabolism of ALA to DHA requires three
desaturation and three elongation steps that in many species
can be performed by fatty acyl desaturase (FADS) enzymes, Δ6
and Δ5 desaturase, and elongation of very long-chain fatty acid
(ELOVL) enzymes, ELOVL5 and ELOVL2. The metabolism of
ALA to n-3 LC-PUFA has been studied in several ﬁsh species,
including rainbow trout (Oncorhynchus mykiss). However,
most studies of ALA desaturation and elongation have been
conducted on a background of dietary EPA and DHA, which is
an inevitable consequence of using ﬁshmeal as a protein source
in aquaculture feed(3–6). There was increased conversion
of 14C-labelled ALA and EPA to 14C-DHA in hepatocytes isolated
from rainbow trout fed vegetable oil compared with those fed
ﬁsh oil(7). This suggested that dietary EPA and DHA may be
repressing the expression of at least some of the DHA biosyn-
thetic genes, and therefore studies that include dietary EPA and
DHA may not allow measurement of the full potential of dietary
ALA to act as a source of endogenously produced EPA
and DHA.
The recent identiﬁcation and functional characterisation of
ELOVL2(8) and Δ5 desaturase(9) in rainbow trout, together with
the previously characterised ELOVL5(10) and Δ6 desaturase(11),
means that the fatty acid substrate speciﬁcities of the four
Abbreviations: ALA, α-linolenic acid; DPA, docosapentaenoic acid; ELOVL, elongation of very long-chain fatty acid; FADS, fatty acyl desaturase; LC-PUFA, long-
chain PUFA.
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enzymes required for ALA to DHA conversion are well
characterised. However, the regulation of these genes in
response to dietary n-3 fatty acids has not been fully
characterised. We examined the effect of dietary ALA, EPA
or DHA, in isolation and in combination, on the regulation
of expression levels of the four LC-PUFA biosynthetic
genes, FADS2a(Δ6), FADS2b(Δ5), ELOVL5 and ELOVL2, in
rainbow trout.
Methods
Animals and housing
A total of 800 mixed-sex diploid rainbow trout ﬁngerlings
(approximately 2·5 g) were sourced from the Victorian
Department of Primary Industries Hatchery, transferred to
Deakin University’s Aquaculture Research Facility, and
acclimatised to the new environmental conditions in two 1000
litre tanks for 2 weeks. The ﬁsh were fed a commercial diet
(Nova SS, 2mm; Skretting) for 3 d before being fed a low n-3
PUFA reference diet for 2 weeks to reduce baseline tissue EPA
and DHA contents. The experiment was conducted in a ther-
mostatically controlled, closed-loop recirculating freshwater
aquaculture system, with physical and biological ﬁltration and
UV sterilisation. The system was maintained within optimum
temperature and water-quality levels, with a 12 h light–12 h dark
cycle at 13°C± 1°C. All procedures involving ﬁsh handling and
experimentation conformed to the Australian Code of Practice
for the Care and Use of Animals for Scientiﬁc Purposes and
were approved by the Deakin University Animal Ethics
Committee (project ID G37-2014).
Diets and experimental design
Eight iso-proteic and iso-lipidic experimental diets were for-
mulated and manufactured to contain 42% protein and 20% lipid.
The added dietary oil source was the only variable (Table 1).
The oil sources were added at 174 g/kg and included linseed oil
Table 1. Formulation and proximate composition (g/kg dry weight) of the experimental diets
Experimental diet
Low n-3 PUFA ALA EPA DHA ALA+EPA ALA+DHA ALA+EPA+DHA EPA+DHA
Dietary ingredients (g/kg)
Pregel starch* 197·3 197·3 197·3 197·3 197·3 197·3 197·3 197·3
Poultry meal* 116·1 116·1 116·1 116·1 116·1 116·1 116·1 116·1
Wheat gluten† 81·3 81·3 81·3 81·3 81·3 81·3 81·3 81·3
Fishmeal* 58·0 58·0 58·0 58·0 58·0 58·0 58·0 58·0
Blood meal* 58·0 58·0 58·0 58·0 58·0 58·0 58·0 58·0
Meat and bone meal‡ 58·0 58·0 58·0 58·0 58·0 58·0 58·0 58·0
Soyabean meal* 58·0 58·0 58·0 58·0 58·0 58·0 58·0 58·0
Soyaisolate§ 58·0 58·0 58·0 58·0 58·0 58·0 58·0 58·0
Rice protein isolate§ 58·0 58·0 58·0 58·0 58·0 58·0 58·0 58·0
Pea protein isolate§ 58·0 58·0 58·0 58·0 58·0 58·0 58·0 58·0
Vitamin and mineral mix|| 7·0 7·0 7·0 7·0 7·0 7·0 7·0 7·0
Celite¶ 5·0 5·0 5·0 5·0 5·0 5·0 5·0 5·0
Choline* 5·0 5·0 5·0 5·0 5·0 5·0 5·0 5·0
Monosodium phosphate* 4·0 4·0 4·0 4·0 4·0 4·0 4·0 4·0
Lysine* 1·5 1·5 1·5 1·5 1·5 1·5 1·5 1·5
Methionine* 1·0 1·0 1·0 1·0 1·0 1·0 1·0 1·0
Taurine* 1·0 1·0 1·0 1·0 1·0 1·0 1·0 1·0
Vitamin C* 0·5 0·5 0·5 0·5 0·5 0·5 0·5 0·5
ARASCO oil** 12·3 12·9 0·0 4·1 7·4 8·1 5·8 2·7
Sunflower oil†† 39·2 0·0 34·8 32·9 19·2 17·8 24·7 34·3
Hydrogenated soyabean oil‡‡ 122·6 0·0 0·0 0·0 0·0 0·0 0·0 0·0
Linseed oil§§ 0·0 161·2 0·0 0·0 73·8 74·1 47·9 0·0
Incromega EPA 500TG oil|||| 0·0 0·0 139·3 0·0 73·8 0·0 47·9 68·5
Incromega DHA 500TG oil|||| 0·0 0·0 0·0 137·1 0·0 74·1 47·9 68·5
Proximate composition (g/kg)
Protein 436·1 426·9 421·7 423·2 427·5 427·9 412·9 421·1
Lipid 224·6 206·9 191·5 208·6 210·5 212·1 204·9 208·2
Moisture 83·3 67·7 86·3 84·9 84·1 72·3 88·1 77·8
Ash 61·4 66·3 62·0 63·6 64·2 63·4 63·0 63·7
ALA, α-linolenic acid (18 : 3n-3); EPA (20 : 5n-3); DHA (22 : 6n-3).
* Ridley Agriproducts.
† Agri Food Ingredients.
‡ The Midfield Group.
§ Bulk Nutrients Grove.
|| DSM Nutritional Products.
¶ Merck KGaA.
** DSM Nutritional Products.
†† Nuseed Global.
‡‡ Cargill Australia.
§§ Melrose Laboratories.
|||| Croda International Plc.
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(Melrose Laboratories) as a source of ALA, Incromega EPA 500TG
oil (Croda International Plc) as a source of EPA and Incromega
DHA 500TG oil (Croda International Plc) as a source of DHA. The
low n-3 PUFA reference diet contained minimal ALA, EPA and
DHA, whereas the other seven diets were formulated to contain
high ALA, EPA or DHA in isolation or in combination (ALA+EPA,
ALA+DHA, ALA+EPA+DHA or EPA+DHA). Sunﬂower oil
(Nuseed Global) and ARASCO (DSM Nutritional Products) were
used to balance the linoleic acid (18 : 2n-6) and arachidonic acid
(20 : 4n-6) contents of each of the diets.
The experimental diets were produced using a meat mincer
(Model TJ22-B; Brice Australia) ﬁtted with a 3-mm stainless steel
extrusion plate. The feed was dried to 2–3% moisture in a dark,
temperature-controlled fan-forced room at 40°C for 48 h. It was
ground and mechanically sieved through a nest of 2, 1 and
0·5-mm screens. The experimental diets used for the duration of
the trial were a composite collected from the 2 and 1-mm
screens. Diets were stored at approximately 10°C until fed.
The trial consisted of 720 rainbow trout that were weighed
and allocated to twenty-four experimental tanks (140 litre
tanks). The ﬁsh had a mean initial weight of 3·6 (SE 0·1) g and
were stocked at 30 ﬁsh/tank. The ﬁsh were assigned one of
eight experimental diets (3 tanks/treatment) and were fed to
apparent satiety twice daily, at 08.30 hours and 17.00 hours, for
a period of 3 weeks. Total feed intake was recorded at the end
of the trial and mortalities were recorded throughout the trial.
Sampling and chemical analysis
At the end of the 3-week trial, the ﬁsh were euthanised using
30-parts per million AQUI-S (AQUI-S New Zealand Ltd). All ﬁsh
were weighed and 12 ﬁsh per tank were randomly sampled for
analysis. The whole liver and a portion of muscle were removed
from 6 ﬁsh/tank for fatty acid analysis, and samples were stored
on ice during the sampling of each tank and then at −20°C.
A portion of liver and muscle were removed from the remaining
6 ﬁsh/tank for gene expression analysis. These samples were
placed immediately into RNAlater, stored on ice during the
sampling of each tank, followed by storage at 4°C overnight
before being transferred to −80°C.
The proximate compositions of experimental diets were
determined according to standard procedures(12). Brieﬂy,
protein (N× 6·25) was measured using an automated Kjeltec
2300 (Foss Tecator), moisture by drying samples in an oven at
105°C to a constant weight and ash by incinerating samples
in a mufﬂe furnace (Wit; C & L Tetlow) at 550°C for 18 h.
Lipid content was determined using chloroform–isopropanol
(2:1, v/v) extraction basically according to the method of Folch
et al.(13), and 0·005% (w/v) butylated hydroxyanisole was
added to reduce lipid oxidation during processing.
Rainbow trout liver fatty acyl desaturase 2a(Δ6), fatty acyl
desaturase 2b(Δ5), elongation of very long-chain fatty acid 2
and elongation of very long-chain fatty acid 5 gene expression
A TissueLyser (Qiagen) was used to disrupt and homogenise
approximately 15mg of RNAlater-stabilised liver tissue. Total RNA
was extracted with the RNeasy kit (Qiagen) and the quantity and
quality of RNA were determined by measuring absorbance at 260
and 280nm (NanoDrop Technologies Inc.). Quantitative RT-PCR
(qRT-PCR) was performed using an Applied Biosystems Quant-
Studio 7 Flex Real-Time PCR System with the Superscript ІІІ
Platinum SYBR Green One-Step qRT-PCR kit (Invitrogen Australia
Pty Ltd). Each 10 µl reaction contained 10ng of complementary
DNA (cDNA), 5 µl 2× SYBR Green reaction mix, 0·2 µl
SuperScript III RT/Platinum Taq Mix and 200nM of each primer
(Table 2). The cycling conditions were as follows: at 50°C for
3min, at 95°C for 5min, 40 cycles of 95°C for 15 s and 60°C for
30 s, followed by 40°C for 1min and a melt curve analysis of 1°C
increments from 60 to 95°C. Agarose gel electrophoresis of the
products and melt curve analysis were used to ensure that a
single speciﬁc product of expected size was obtained.
Ampliﬁcations were carried out with negative controls (no cDNA
template control). Gene expression data are expressed as mean
values with their standard errors (n 3) normalised for the
geometric mean of the expression levels of two housekeeping
genes, β-ACTIN and elongation factor 1α, in relative units.
Fatty acid analysis
Total lipid was extracted from feeds and trout tissues using
chloroform–isopropanol (2:1, v/v) basically according to the
Table 2. Primers used for quantitative RT-PCR amplification of fatty acyl desaturase (FADS) 2a(Δ6), FADS2b(Δ5), elongation of very long-chain fatty acid
(ELOVL) 5, ELOVL2, β-ACTIN and elongation factor 1α (EF1α), including the GenBank accession number of the sequence used for primer design
Gene Accession number Primer Sequence 5′→ 3′ Amplicon size
FADS2a(Δ6) NM_001124287 F TAGTTTCCCCAGACGTTTGTGTC 69
R CCAAAAAATGATTAAAACAATTACG
FADS2b(Δ5) JQ087459 F GGACATTTCCTGGATGTTTTTGAT 78
R TCTGACAAGGATTAAAACAATTATA
ELOVL5 AY605100 F CTATGGGCTCTCTGCTGTCC 106*
R TATCGTCTGGGACATGGTCA
ELOVL2 KM244737 F GATGCCTGCTCTTCCAGTTC 141*
R CATTGGTGGAGACAGTGTGG
β-ACTIN NM_001124235 F TTTGAGACCTTCAACACCCC 142
R GAGCGTAGCCCTCGTAGATG
EF1α NM_001124339 F GGATGGAAGGTCGAACGTAA 128
R TTGTAGACATCCTGGAGGGG
* Primers previously published(8).
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method of Folch et al.(13). Lipid weight was determined after
drying the extracted lipid under N2. Phospholipid fatty acids of
liver and muscle tissues were separated by TLC using a mobile
phase of petroleum ether–acetone (3:1, v/v). Total lipid from
feeds or phospholipid fatty acids from liver and muscle tissue
were methylated in 1% (v/v) sulphuric acid in methanol for 3 h
at 70°C to prepare fatty acid methyl esters that were extracted in
heptane and analysed by GC as described previously(14). The
identity of each fatty acid peak in the chromatogram was
ascertained by comparing its retention time to authentic lipid
standards (Nu-Chek Prep). Fatty acid methyl esters were quan-
tiﬁed using GC Chemstation software (Agilent Technologies). All
solvents contained 0·005% (w/v) butylated hydroxyanisole as an
antioxidant. The amount of each fatty acid was expressed as a
percentage of the total amount of all fatty acids.
Statistical analysis
The expression of LC-PUFA biosynthetic genes in ﬁsh con-
suming the experimental diets compared with the low n-3
PUFA reference diet was analysed by one-way ANOVA with
Dunnett’s post hoc test. The liver and muscle fatty acid data
were analysed by one-way ANOVA with Tukey’s post hoc test.
All analyses were carried out using Graphpad Prism version
5.03 for Windows (Graphpad Software). Statistical signiﬁcance
was set at P< 0·05.
Results
Experimental diets
The low n-3 PUFA diet contained minimal ALA, EPA and DHA
with the total n-3 PUFA being 1·0% of total fatty acids (Table 3).
The high-ALA diet contained 35·7% ALA, the high-EPA diet
contained 29·0% EPA, and the high-DHA diet contained 33·0%
DHA (Table 3). The experimental diets with a combination of
two n-3 PUFA (ALA+ EPA, ALA+DHA or EPA+DHA)
contained equal amounts of both n-3 PUFA, which were
approximately half of the amount in the high-ALA-, -EPA- or
-DHA-only diets (Table 3). Likewise, the ALA+EPA+DHA diet
contained equal amounts of ALA, EPA and DHA, which were
each one third of the amount in the high-ALA-, -EPA- or -DHA-
only diets (Table 3). The total n-6 PUFA concentrations were
17·0–21·5% of total fatty acids across all diets (Table 3). The
total lipid content was similar across all diets, with an average of
20·8% (Table 1).
Growth performance
The ﬁnal body weights of rainbow trout were not statistically
different between any of the dietary treatments (Table 4).
Similarly, no signiﬁcant differences were observed for weight
gain, dry feed intake, feed conversion ratio, speciﬁc growth rate
and survival between any of the dietary treatments (Table 4).
The effect of dietary n-3 PUFA on liver long-chain PUFA
biosynthetic gene expression
The effect of dietary ALA, EPA or DHA on the regulation of
expression levels of the four LC-PUFA biosynthetic genes was
compared with the low n-3 PUFA diet. Dietary ALA reduced the
expression of FADS2a(Δ6) and FADS2b(Δ5), although the
reduced level of FADS2a(Δ6) was not statistically signiﬁcant
(Fig. 1(a) and (b)). Dietary EPA signiﬁcantly reduced the
expression of ELOVL2 only (Fig. 1(d)). Dietary DHA reduced
Table 3. Fatty acid composition (percentage of total fatty acids) of the experimental diets
Experimental diet
Low n-3 PUFA ALA EPA DHA ALA+EPA ALA+DHA ALA+EPA+DHA EPA+DHA
18 : 3n-3 (ALA) 0·3 35·7 1·0 0·6 17·4 17·7 11·8 0·7
18 : 4n-3 (SDA) 0·0 0·0 7·3 0·6 4·4 0·4 3·1 4·6
20 : 4n-3 0·0 0·0 0·8 0·0 0·5 0·0 0·5 0·7
20 : 5n-3 (EPA) 0·3 0·3 29·0 5·1 18·8 2·9 14·1 20·6
22 : 5n-3 (DPA) 0·1 0·1 1·1 1·5 0·7 0·9 1·0 1·5
22 : 6n-3 (DHA) 0·3 0·3 7·4 33·0 5·2 19·1 15·8 22·7
Total n-3 C18 PUFA 0·3 35·7 8·3 1·2 21·8 18·1 14·9 5·3
Total n-3 LC-PUFA* 0·7 0·7 38·3 39·6 25·2 22·9 31·4 45·5
18 : 2n-6 14·4 18·5 18·2 15·8 16·8 16·6 16·4 15·3
18 : 3n-6 0·2 0·2 0·4 0·2 0·3 0·2 0·3 0·3
20 : 3n-6 0·2 0·2 0·2 0·2 0·2 0·2 0·2 0·3
20 : 4n-6 2·1 2·3 1·5 2·1 2·3 2·3 2·2 2·1
Total n-6 PUFA 17·0 21·3 20·8 21·5 19·9 21·1 20·5 19·9
16 : 0 12·8 9·8 8·7 7·8 7·9 8·3 7·6 6·6
18 : 0 54·8 6·1 3·7 5·5 4·3 5·4 4·5 3·8
Total SFA 69·5 17·1 13·8 15·2 13·4 15·2 13·4 11·8
16 : 1n-7 0·7 0·8 1·8 1·2 1·1 0·9 1·1 1·2
18 : 1n-9 11·0 23·1 15·2 16·2 17·0 18·8 16·3 13·1
18 : 1n-7 0·5 1·0 0·9 1·3 0·8 1·1 1·0 1·0
Total MUFA 12·3 25·1 18·6 22·0 19·4 22·5 19·6 17·1
ALA, α-linolenic acid (18 : 3n-3); EPA, 20 : 5n-3; DHA, 22 : 6n-3; SDA, stearidonic acid (18 : 4n-3); DPA, docosapentaenoic acid (22 : 5n-3); LC-PUFA, long-chain PUFA.
* Total n-3 LC-PUFA is the sum of 20 : 3n-3, 20 : 4n-3, 20 : 5n-3, 22 : 5n-3 and 22 : 6n-3.
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the expression of all four genes, with FADS2a(Δ6) and FADS2b
(Δ5) down-regulated by 4·2-fold each, but the reduced ELOVL5
expression did not reach statistical signiﬁcance (Fig. 1).
The effect of combinations of dietary ALA, EPA or DHA on
FADS2a(Δ6), FADS2b(Δ5), ELOVL5 and ELOVL2 expression
was compared with the effect of the low n-3 PUFA diet. Dietary
Table 4. Growth performance and feed efficiency of rainbow trout fed the experimental diets for 3 weeks*
(Mean values with their standard errors; n 3)
Diet
Low n-3 PUFA ALA EPA DHA ALA+EPA ALA+DHA ALA+EPA+DHA EPA+DHA
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
IBW (g) 3·4 0·2 3·6 0·2 3·6 0·1 3·6 0·2 3·5 0·1 3·5 0·2 3·7 0·3 3·8 0·1
FBW (g) 6·2 0·3 6·5 0·3 5·7 0·3 5·9 0·3 6·3 0·4 6·4 0·1 6·1 0·3 6·4 0·2
WG (g) 2·8 0·2 2·9 0·1 2·0 0·2 2·3 0·1 2·8 0·3 2·9 0·2 2·4 0·1 2·6 0·1
WG† (%) 81·0 4·0 81·3 3·9 56·1 3·5 62·8 1·5 80·0 8·2 84·6 12·4 66·5 8·5 67·4 2·2
Dry feed intake (g/21 d) 134·9 3·5 135·4 1·1 136·4 3·8 145·7 4·2 136·9 2·0 147·0 3·6 136·7 0·2 142·1 2·5
FCR‡ 1·7 0·1 1·6 0·1 2·4 0·2 2·3 0·1 1·9 0·3 2·1 0·6 2·0 0·1 2·0 0·1
SGR§ (% gain/d) 2·8 0·1 2·8 0·1 2·1 0·1 2·3 0·1 2·8 0·2 2·9 0·3 2·4 0·2 2·5 0·1
Survival|| (%) 98·9 1·1 98·9 1·1 97·8 1·1 97·8 1·1 96·7 1·9 94·4 5·6 98·9 1·1 96·7 1·9
ALA, α-linolenic acid (18 : 3n-3); EPA, 20 : 5n-3; DHA, 22 : 6n-3; IBW, initial body weight; FBW, final body weight; WG, wet weight gain.
* There were no significant differences between dietary treatments in any parameter.
† WG (%), percentage weight gain=100× ((FBW− IBW)/IBW).
‡ FCR, feed conversion ratio=dry feed intake (g)/WG (g).
§ SGR (% gain/d), specific growth rate=100× (ln FBW− ln IBW)/21 d.
|| Survival (%)=100× (number of fish remaining on day 21/initial number of fish).
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Fig. 1. Rainbow trout liver fatty acyl desaturase (FADS)2a(Δ6) (a), FADS2b(Δ5) (b), elongation of very long-chain fatty acid (ELOVL)5 (c) and ELOVL2 (d) gene
expression after dietary intervention. Values are means (n 3), with standard errors represented by vertical bars normalised for the geometric mean of the expression
levels of two housekeeping genes, β-ACTIN and elongation factor 1α (EF1α), in relative units (RU). The mean value was significantly different from that of the low n-3
PUFA diet: ** P< 0·01, *** P< 0·001. ALA, α-linolenic acid (18 : 3n-3); EPA (20 : 5n-3); DHA (22 : 6n-3).
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EPA+DHA signiﬁcantly reduced the expression of
FADS2a(Δ6), FADS2b(Δ5) and ELOVL2, although the 13·7-fold
down-regulation of FADS2b(Δ5) was greater than the 4·8- and
4·5-fold down-regulation of FADS2a(Δ6) and ELOVL2, respec-
tively (Fig. 1). Dietary ALA+EPA+DHA or ALA+DHA also
signiﬁcantly reduced the expression of FADS2a(Δ6), FADS2b
(Δ5) and ELOVL2 (Fig. 1). Dietary ALA, EPA or DHA, in
isolation or in combination, did not signiﬁcantly change the
expression of ELOVL5 compared with the low n-3 PUFA diet
(Fig. 1(c)).
The effect of dietary n-3 PUFA on the liver phospholipid
n-3 PUFA composition
The proportion of stearidonic acid (SDA, 18 : 4n-3) in the liver
increased with dietary ALA (Table 5). The proportion of EPA in
the liver increased with dietary ALA and EPA, with the latter
resulting in larger increases (Table 5). EPA levels in the liver
were signiﬁcantly higher with dietary ALA alone compared
with those with dietary ALA+DHA (Table 5). Liver doc-
osapentaenoic acid (DPA, 22 : 5n-3) increased with dietary ALA
or EPA, in isolation or in combination with each other or with
DHA, with the exception of dietary ALA+DHA in which DPA
levels remained as low as with dietary DHA alone (Table 5).
Liver DHA in ﬁsh consuming the low n-3 PUFA diet was sig-
niﬁcantly lower than in ﬁsh on any other diet. The proportion of
DHA in the liver was increased by 3- or 3·7-fold when ﬁsh were
consuming dietary ALA or EPA, respectively, compared with
ﬁsh consuming the low n-3 PUFA diet (Table 5). Fish
consuming dietary DHA had signiﬁcantly higher liver DHA
levels compared with that in ﬁsh on any other diet, with the
exception of ﬁsh consuming dietary EPA+DHA.
The effect of dietary n-3 PUFA on the muscle phospholipid
n-3 PUFA composition
The proportion of SDA in muscle increased with dietary ALA
(Table 6). The proportion of EPA in muscle increased with
dietary ALA and EPA, with the latter resulting in larger
increases, similar to the pattern observed in the liver (Table 6).
The percentage of DPA in the muscle increased to a greater
extent with dietary EPA alone compared with dietary EPA and
DHA (ALA+ EPA+DHA and EPA+DHA diets) (Table 6).
Muscle DHA in ﬁsh consuming the low n-3 PUFA diet was
signiﬁcantly lower than that in ﬁsh on any other diet (Table 6).
In these ﬁsh, the proportion of DHA in muscle was 21·7% of
total fatty acids (Table 6), which was higher than the proportion
of DHA in the liver, which was 10·8% of total fatty
acids (Table 5). The proportion of DHA in muscle was
increased by 1·2- or 1·6-fold when ﬁsh were consuming dietary
ALA or EPA, respectively, compared with the low n-3 PUFA diet
(Table 6).
Discussion
This study is unique in that all of the four LC-PUFA biosynthetic
genes were examined and the effects of individual n-3 PUFA
concentrations in the diet were assessed. There have been
studies that have directly or indirectly examined the effect of
ﬁsh oil on some of the elongase and/or desaturase enzymes,
and in general these were ﬁsh oil–vegetable oil compar-
isons(4–6,15–17). In addition, the vegetable oil diets containing
ALA had a background of EPA and DHA from the inclusion of
7–58% ﬁshmeal in the dietary formulations, which made
examining the effect of ALA on the LC-PUFA biosynthetic genes
challenging(4–6,16,17). Dietary ﬁshmeal was reduced to 5·8% in
Table 5. Lipid content (percentage of wet weight) and fatty acid composition (percentage of total fatty acids) of liver phospholipids after dietary intervention
(Mean values with their standard errors; n 3)
Diet
Low n-3 PUFA ALA EPA DHA ALA+EPA ALA+DHA ALA+EPA+DHA EPA+DHA
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Lipid content 4·9 0·3 5·1 0·6 3·9 0·2 4·9 0·2 4·5 0·2 4·0 0·4 4·9 0·0 4·0 0·3
Fatty acids
18 : 3n-3 (ALA) 0·0 2·0a 0·2 0·1b 0·0 0·0 1·3a,c 0·4 1·3a,d 0·1 0·8b,c,d 0·0 0·1b 0·0
18 : 4n-3 (SDA) 0·0 1·1a 0·1 0·4b 0·0 0·0 0·3b 0·0 0·3b 0·0 0·2b 0·0 0·0
20 : 4n-3 0·0 0·7a 0·1 0·3b,c 0·0 0·0 0·4b 0·0 0·2c 0·0 0·3b,c 0·0 0·2c 0·0
20 : 5n-3 (EPA) 0·2a 0·0 3·1b 0·1 8·2c 0·2 1·3d 0·1 5·7e 0·1 1·5d 0·0 3·8f 0·0 4·4g 0·1
22 : 5n-3 (DPA) 0·3a 0·0 1·8b 0·2 1·8b 0·1 0·4a,c 0·0 1·9b 0·4 0·5a,c 0·0 1·1a,b 0·0 1·2b,c 0·0
22 : 6n-3 (DHA) 10·8a 0·1 31·3b 0·7 40·4c 0·1 44·9d 1·0 36·0e 1·7 40·8c 0·8 39·0c,e 0·3 42·1c,d 0·5
Total n-3 C18 PUFA 0·0 2·9
a 0·5 0·4b,c 0·2 0·0 1·5b 0·4 1·7a,b 0·3 0·9b,c 0·1 0·1c 0·0
Total n-3 LC-PUFA* 11·4a 0·1 37·4b 0·5 50·9c 0·3 46·6d,e 1·0 44·5d,e 1·4 43·3d 0·8 44·5d,e 0·3 47·9c,e 0·6
18 : 2n-6 4·8a 0·1 4·2a,b 0·3 3·8b,c 0·2 3·5b,c 0·2 3·4b,c 0·3 3·5b,c 0·0 3·1c 0·1 3·2c 0·1
18 : 3n-6 0·5a 0·0 0·2b 0·0 0·0 0·0 0·1b 0·0 0·1b 0·0 0·1b 0·0 0·1b 0·0
20 : 3n-6 2·5a 0·0 1·5b 0·0 0·5c 0·0 0·5c,d 0·0 0·8c,d 0·2 0·7c,d 0·1 0·8d 0·0 0·5c,d 0·0
20 : 4n-6 10·0a 0·4 6·3b 0·2 3·8c 0·2 3·7c,d 0·4 3·3c,d 0·2 3·7c,d 0·2 3·5c,d 0·2 2·5d 0·2
Total n-6 PUFA 40·7a 0·5 14·6b 0·6 9·6c 0·2 11·6c,d 0·7 9·7c 0·4 12·0d 0·3 8·5c,e 0·3 7·2e 0·3
Total SFA 28·6 0·2 29·8 0·8 28·7 0·6 29·0 0·9 30·7 1·5 29·8 0·6 32·2 0·2 32·1 0·4
Total MUFA 19·4a 0·5 15·8b 0·3 10·9c 0·2 12·8c,d 0·8 14·1b,d 0·6 13·6b,d 0·3 13·9b,d 0·4 12·8c,d 0·5
ALA, α-linolenic acid (18 : 3n-3); EPA, 20 : 5n-3; DHA, 22 : 6n-3; SDA, stearidonic acid (18 : 4n-3); DPA, docosapentaenoic acid (22 : 5n-3); LC-PUFA, long-chain PUFA.
a,b,c,d,e,f,g Mean values within a row with unlike superscript letters were significantly different (P<0·05) as determined by ANOVA.
* Total n-3 LC-PUFA is the sum of 20 : 3n-3, 20 : 4n-3, 20 : 5n-3, 22 : 5n-3 and 22 : 6n-3.
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the present study, resulting in experimental diets with minimal
EPA and DHA, both 0·3% of total fatty acids.
The present study found that the highest expressions of all
four LC-PUFA biosynthetic genes were in ﬁsh fed low dietary
n-3 PUFA. The expressions of FADS2a(Δ6), FADS2b(Δ5)
and ELOVL2 were variously repressed by the individual n-3
PUFA, none of which repressed the expression of ELOVL5. Of
the fatty acids tested, dietary DHA had the largest and most
consistent effect in down-regulating all four genes, including
reduced expression of ELOVL5, although it was not statistically
signiﬁcant. This is a possible explanation for some of the
effects of dietary ALA on the liver content of some of
the downstream products of its metabolism. For example, the
proportion of SDA resulting from dietary ALA was decreased by
the addition of DHA to the diet (1·1 v. 0·3% of total fatty acids).
This could be due to the observed DHA repression of
FADS2a(Δ6), which codes for Δ6 desaturase, the enzyme
responsible for SDA synthesis. Likewise, the proportion
of DPA in ﬁsh fed dietary ALA was decreased by the addition of
DHA to the diet (1·8 v. 0·5% of total fatty acids). This could be
due to the observed DHA repression of ELOVL2, and
subsequently the ELOVL2 enzyme responsible for DPA synth-
esis from EPA.
Irrespective of diet, ﬁsh fed diets supplemented with n-3
PUFA showed higher levels of DHA in the liver compared with
ﬁsh fed the low n-3 PUFA diet. For example, ﬁsh fed dietary
ALA showed a 3-fold increase in liver DHA compared with ﬁsh
fed the low n-3 PUFA diet, despite dietary DHA being identical
(0·3% of total fatty acids). Similar changes were seen in muscle
DHA. Clearly, these juvenile ﬁsh exhibited an active LC-PUFA
biosynthetic pathway that had an impact on the phospholipid
fatty acid composition of the liver and muscle tissue. It is
possible that adult ﬁsh may be less responsive but the use of
juveniles allowed greater experimental manipulation.
Endogenously synthesised DHA appeared to have a different
effect from dietary DHA on FADS2a(Δ6) and FADS2b(Δ5) gene
expression. For example, dietary EPA resulted in 40·4% DHA in
the liver with no change in expression of FADS2a(Δ6) or
FADS2b(Δ5) compared with the low n-3 PUFA diet of 10·8%
DHA. However, dietary EPA+DHA down-regulated the
expression of FADS2a(Δ6) and FADS2b(Δ5) by 4·8- and 13·7-
fold, respectively, but resulted in the same amount of liver DHA
(42·1%) as that in the dietary EPA group. This is a very important
and novel observation that warrants further tailored investiga-
tions. Our ﬁndings on reduced FADS2a(Δ6) expression in ﬁsh
fed dietary EPA+DHA are in agreement with a previous report
in rainbow trout that found that FADS2a(Δ6) expression was 4·1-
fold lower in ﬁsh fed a ﬁsh oil diet compared with a vegetable oil
diet devoid of n-3 LC-PUFA(15). Similarly, in Atlantic salmon,
dietary EPA+DHA signiﬁcantly down-regulated the expression
of Δ5fad, Δ6fad and elovl2 compared with a vegetable oil diet
low in n-3 LC-PUFA; yet dietary EPA alone had no effect(18).
Previously, liver ELOVL5 expression was shown to be
unchanged between rainbow trout fed a ﬁsh oil diet and those
fed increasing dietary ALA (8·2–32·4% of total fatty acids)(16).
We have now found that neither dietary ALA, EPA nor DHA in
isolation or in combination has a signiﬁcant effect on the
expression of ELOVL5 compared with a diet low in n-3 PUFA.
Of particular interest is the differing effect of dietary EPA on
signiﬁcantly down-regulating the expression of ELOVL2, but not
ELOVL5. Previous functional characterisation of the ELOVL2
and ELOVL5 enzymes demonstrated that their substrate
speciﬁcities towards EPA were similar at the concentrations
examined, but ELOVL2 could further elongate EPA to DPA and
Table 6. Lipid content (percentage of wet weight) and fatty acid composition (percentage of total fatty acids) of muscle phospholipids after dietary
intervention
(Mean values with their standard errors; n 3)
Diet
Low n-3 PUFA ALA EPA DHA ALA+EPA ALA+DHA ALA+EPA+DHA EPA+DHA
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Lipid content 2·3 0·2 2·8 0·1 3·2 0·3 2·6 0·4 2·2 0·2 2·5 0·2 2·6 0·2 2·5 0·2
Fatty acids
18 : 3n-3 (ALA) 0·3a 0·0 7·5b 0·2 0·3a 0·0 0·3a 0·0 3·3c 0·1 3·1c 0·0 2·3d 0·0 0·3a 0·0
18 : 4n-3 (SDA) 0·2a 0·0 1·3b 0·1 0·5c 0·0 0·2a 0·0 0·7c 0·0 0·4d 0·0 0·5c,d 0·1 0·4d 0·0
20 : 4n-3 0·3a 0·0 1·0b 0·0 0·6c,d 0·0 0·3a 0·0 0·7c 0·0 0·5d 0·0 0·6c,d 0·0 0·5c,d 0·0
20 : 5n-3 (EPA) 3·4a 0·2 4·4b 0·2 11·1c 0·2 4·1a,b 0·1 8·6d 0·3 3·5a,b 0·1 7·1e 0·1 7·7d,e 0·4
22 : 5n-3 (DPA) 1·1a 0·0 1·6b 0·0 2·6c 0·0 1·4b,e 0·0 2·4d 0·0 1·3e 0·0 2·0f 0·1 2·0f 0·0
22 : 6n-3 (DHA) 21·7a 0·0 26·9b 0·8 33·7c,e 0·4 40·3d 0·9 30·4b,c 0·8 36·2e 0·6 33·9c,e 1·3 35·9 0·7e
Total n-3 C18 PUFA 0·5
a 0·0 8·7b 0·2 0·9a 0·0 0·4a 0·0 4·0c 0·2 3·3d 0·2 2·9d 0·1 0·7a 0·0
Total n-3 LC-PUFA* 26·6a 0·3 34·4b 1·0 48·0c 0·2 46·2c,e 0·8 42·3d 0·6 41·8d 0·5 43·7d,e,f 1·3 46·2c,f 0·6
18 : 2n-6 10·2a 0·4 7·5b 0·1 5·4c 0·1 5·4c 0·1 5·8c 0·1 5·8c 0·1 5·9c 0·2 5·6c 0·1
18 : 3n-6 0·7a 0·0 0·3b 0·0 0·2b 0·0 0·2b 0·0 0·2b 0·0 0·2b 0·0 0·3b 0·0 0·2b 0·0
20 : 3n-6 1·6a 0·1 1·0b 0·0 0·6c 0·0 0·6c 0·0 0·7c 0·0 0·7c 0·0 0·7c 0·0 0·6c 0·0
20 : 4n-6 6·9a 0·0 5·2b 0·2 3·1c 0·1 3·4c,d 0·0 3·7d,e 0·0 3·7d,f 0·1 3·5c,e,f 0·1 3·1c 0·1
Total n-6 PUFA 28·5a 0·3 16·3b 0·2 12·6c 0·1 13·7c,d 0·2 13·6c,d 0·2 14·4d,e 0·4 13·9c,e 0·5 13·0c 0·1
Total SFA 26·9 0·3 27·0 0·2 27·0 0·1 27·0 0·1 27·9 0·1 27·7 0·2 26·9 0·1 27·6 0·5
Total MUFA 17·6a 0·4 14·1b 1·0 11·8b 0·2 12·7b 0·4 12·5b 0·4 12·7b 0·3 12·8b 0·8 12·6b 0·3
ALA, α-linolenic acid (18 : 3n-3); EPA, 20 : 5n-3; DHA, 22 : 6n-3; SDA, stearidonic acid (18 : 4n-3); DPA, docosapentaenoic acid (22 : 5n-3); LC-PUFA, long-chain PUFA.
a,b,c,d,e,f Mean values within a row with unlike superscript letters were significantly different (P<0·05) as determined by ANOVA.
* Total n-3 LC-PUFA is the sum of 20 : 3n-3, 20 : 4n-3, 20 : 5n-3, 22 : 5n-3 and 22 : 6n-3.
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then to 24 : 5n-3(8). Therefore, the down-regulation of ELOVL2
by dietary EPA may have a downstream effect on the synthesis
of DPA and subsequently DHA, which ELOVL5 cannot com-
pensate for because of the lack of activity towards DPA(8).
Atlantic salmon is closely related to rainbow trout and has Δ6
desaturase(19,20), Δ5 desaturase(21), Elovl5a(21,22), Elovl5b(22) and
Elovl2(22) enzymes that have been functionally characterised and
shown to be responsible for the metabolism of ALA to DHA. The
expression of the Atlantic salmon Δ6fad_a, Δ6fad_b, Δ6fad_c,
Δ5fad, elovl5a, elovl5b and elovl2 liver transcripts has been
examined in response to dietary ﬁsh oil replacement with
vegetable oil diets low in n-3 LC-PUFA and high in C18 PUFA.
Collectively these studies showed that Δ6fad_a, Δ5fad and
elovl2 expression was up-regulated in vegetable oil-fed Atlantic
salmon compared with ﬁsh oil-fed salmon(19,20,22–27), as we have
seen in rainbow trout. However, in many of these studies the
expression of the Atlantic salmon elovl5a and elovl5b genes was
inconsistent with reports of down-regulation of elovl5a(25),
up-regulation of elovl5b(22) or no effect on elovl5a or
elovl5b(22,24,25) in response to dietary vegetable oil compared
with ﬁsh fed ﬁsh oil. The Atlantic salmon elovl5a and elovl5b
may be regulated differently by dietary n-3 PUFA or by condi-
tions such as water temperature and ﬁsh size, although this is not
fully understood. In comparison, juvenile rainbow trout ELOVL5
expression does not seem to be changed signiﬁcantly in
response to different dietary n-3 PUFA when reared at water
temperatures between 13 and 15°C(16).
The present gene regulatory study has shown that
FADS2a(Δ6), ELOVL5 and ELOVL2 are most highly expressed
when diets are high in ALA with no added EPA or DHA. Con-
versely, the expression of all four genes was down-regulated by
dietary EPA and DHA, with DHA having the larger and more
consistent effect, although ELOVL5 expression was the least
responsive to dietary n-3 PUFA changes. These ﬁndings should
be considered when optimising diets containing vegetable oils
and/or ﬁsh oil or ﬁshmeal to achieve maximum DHA synthesis.
A study using larger ﬁsh and a longer feeding period is war-
ranted to determine the impact on the percentage of DHA in the
edible muscle portion of rainbow trout.
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